The 141st Annual Meeting of the Pharmaceutical Society of Japan (Hiroshima)

Presentation information

Print

Oral Presentation

(E) Biopharmaceutics

[27V11-pm] リスクマネジメント/医薬品情報/薬物治療（がん）①

Sat. Mar 27, 2021 3:03 PM - 4:39 PM [Room V11] Oral Presentation 11 (Online)

座長：河原 昌美（愛知学院大薬）、内田 まやこ（大阪薬大）

4:27 PM - 4:39 PM

[27V11-pm17S] PI3K/Akt pathway activation is involved with MEK inhibitor resistance in colorectal carcinoma

○yuta yamamoto1, Masanobu Tsubaki1, Tomoya Takeda1, Yusuke Morii1, Katsumasa Tsurushima1, Shozo Nishida1 (1. Dept. of Pharmacotherapy, Fac of Pharmacy, Kindai Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password